Interventional pain modalities provide alternative analgesia in patients who are intolerant of pharmacologic agents, have comorbidities that require multiple medications, or have pain refractory to oral medications.
Many patients with craniofacial pain syndromes such as trigeminal neuralgia, cluster headache, and migraine have an adequate response to pharmacologic therapies.
Individuals with non-migraine headache have a higher risk for tinnitus, sensorineural hearing impairment, and sudden deafness than individuals without chronic headache.
Headache specialist was more likely to use triptans, while non-headache specialists and the headache specialist started prophylaxis at similar rates in eligible participants.
Revised criteria from the third edition of the International Classification of Headache Disorders (ICHD-3), can differentiate between chronic cluster headache (CCH) and episodic cluster headache (ECH) and may increase the number of CCH diagnoses.
The authors refute a systematic review and meta-analysis of literature on greater occipital nerve block for the treatment of chronic migraine headaches by Shauly and colleagues and published in Plastic and Reconstructive Surgery, citing extensive limitations and claiming the study ultimately raises more questions than answers.
